Vantage Health Secures FDA Clearance for AI-Assisted Diagnostic Device
Vantage Health received FDA 510(k) clearance for VH-Scan, an AI-assisted cardiovascular diagnostic device.
Section
Health
Healthcare, biotech, medical devices, and clinical news.
Cedarleaf Therapeutics Begins Phase 2 Trial for Chronic Pain Treatment
Cedarleaf Therapeutics dosed the first patients in a Phase 2 trial of CL-207, a non-opioid chronic pain treatment.